"Kancer Limited aims to be a leading development based company
in cancer treatments"
Kancer Business Model:
Focussing funds spent on controlled risk and high opportunity
Minimisation of organisational overheads
through strategic business collaborations and appropriate
Combine in-house development with targeted
international collaborations to expand portfolio;
Commitment to good corporate governance
and scientific practices;
Out-licence products, if appropriate,
in Phase II of development;
Reserve certain co-promotional rights
to build a future specialist sales capability; and
Use the national and international capital
markets to finance progress.